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ESSENTIAL 'fHROMBOCYTOPENIC PURPURA

Essential Thranbooytopenic Purpura Hemorrhagica belongs to
oJJe of the heterogenous groups of affections generally classified
as belonging to the hemorrhagic diseases; thought as late as the
beginning o.f the century to be dependent upon a hemorrhagic diathesis, -- diathesis referring to a tendency. inherited or acquired to bleed -- chiefly from the capillaries.

In order that we

may relegate this condition to a distinct category, let us briefly review the more distinctive features of the affection.
'fhranbooytopenic Purpura is an affection, proceeding through
an acute, subacute, or chronic course. characterized clinically
by hemorrhage into the skin and mucous membranes that cannot be

controlled by the use of ordinary hemoatatios.
The condition is usually not hereditary. but congenital
and familial forms have been described.

It occurs chiefly in

adolescence bpt may occur at alJIY age. The acute attack may appear, run its course in two or three days eDiing .fatally; or after two to three weeks may eventually cease as abruptly as it
began or pass into the subs.cute or chronic stages.
The condition usually starts with petechial and
hemorrhages into the skin. vere oases•

eoc~otic

over the entire body in more se-

These petechiae also occur in the buccal mucous

membrane, palate and pharymt.

Hemorrhage from the gums. nose,

and less frequently the stomach, intestines and kidneys are

480980

(2)

prominent features when present and girls may present menorrhagia
or metrorrhagia.
The vulnerability of the capillaries is an outstanding feature
since the slightest trauma or static resistance

(capillaryresis~ance

test) results in a shower of petecbiae. The contimed loss of
blood results in a marked anaemia and the patient may become weak.
incapacitated and bedridden.

Remissions are common but exsangui-

nation may eventually result leading to a fatal termination •
. Fever may be present but usually accompanies the extravasation of
large amounts of blood where absorption or the blood clots leads
to byperpyrexia. .A.s Rosenthal (96) describes the typical sufferer

r
'·

• - - - - The· pictur~ is that of a young ghastly white,
blanched faced individual. bedridden• with dried blood crusts on
the lips, the teeth covered with clotted remnants or blood arising

tram bleeding gums J and from the noatrils ·may be seen extruding,,
hemorrhagic clots from which oozes fluid blood which trickles ·
down over the lips. - - - - •
.Attempts at stopping this bleeding by such ordinary agencies
as tam.ponage; transfusions, calcium salts, thrombalcinase,, etc •• ·
meet· as a rule with no success.
Examination of' the blood of these patients give certain
characteristics of the disease which reveal at least in part,,
the pathogenesis and individualise it fraa other forms of' purpura.

First, there is a marked dimunition in the number of platelets, usually from the normal of

2so.ooo

to less than 100,000,

(3)

more rarely to total absence.

It is this characteristic of the

disease that gifts it the title of Thranbocytopenio purpura.
Secondly, if the blood is permitted to clot, which it does
in normal time, the clot remains UJU:etracted instead of shrinking from the walls of the tube as it does normally, exuding serum
as the process occurs. This at once differentiates the condition
from hemophilia where the clotting time is markedly delayed and
imperfectly executed, and though, a:t'ter the clot forms, retraction occurs.
The third important hematological finding is an increased
bleeding time -- the time necessary for capillary bleeding to
cease. Norm.ally, a small puncture wound ceases to bleed tram
one and a half to three minutes; but in this affection may take
ten or more minutes before cessation of the capillary oozing.
In other respects the blood picture shows only compensa-

tory changes as a result of the hemorrhage.

The leucocyte

picture is variable, but a moderate leucocytosis is the rule.
The red blood cells are usually markedly diminished along with
the hemoglobin, although there is a hypochramia, the color index
being less than one. Smears show a tendency for the red cells to be
m.icrocytic with occasional nonaa.blasts appearing.
The present accepted classification of Purpura is of'fered
by Pratt (92) and Leschke (65).
I•

Thrambocytopenic Purpura
A.

("',.

Essential or primary (Werlhof•s disease)

(4)

B• . Symptomatic
1.

In blood diseases (aplastic anaemia.
leukemia. pernici·ous anaemia)

2.

Infection&. (aepsis. subaeute bacterial
endocarditis• typhoid. tuberculosis• etc.• )

3.

Intoxications (benzol, arsphenamine,
snake venm., etc.)

4.

Radiation (X-ray,· radium, etc.)

6.

Diseases associated with splenomegaly
(hemolytic ieterus, Gauoher•s disease, etc.)

6.

Tumors, metastases, sclerosis of the bone
marrow.

1.

Anaphylaxis

8. Avitaminoses
II. Nonthrombooytopenic purpura
A. Essential or primar,y
1. .Anaphylaotoid (purpura ot Schonleim
and Henoch. and er,ythmna of Osler.)

2.

Miscellaneous (purpura simplex,
purpura fulminans, purpura senilis,
purpura oachectica, mechanical purpura
and familial and hereditary purpura)

Be

Symptomatic or secondary Purpura
1. Various chronic diseases (chronic
nephritis, cardiac or hepatic diseases)

(5)

a.

Inteetions (scarlet fever. typhoid. etc.)

s.

Intoxications (benzol. arsphenamine•
iodine. an.alee venom. etc.)

4.

Avitaminoses (scurvy)

HISTORY

Essential Thrombocytopenia was first separated from the
heterogenous group ot purpuras by lferlhof in 1735.
there have been no controversions of his

class~cal

Although
description.

still certain additions have been made and other types of purpura
described.
In 1883 Krauss {60) reported the observations of Brohm.

tha.t i;he platelets were markedly reduced in number at the time
hemorrhage occurred.

De~a

(20) a trench histologis by independent

work also observed this phenaaena.. and Hayem. ( 42) not only confirmed these observations but demonstrated the role of the platelets in clotting and the non retraotility of the clot in Purpura hemorrhagioa.
Duke (26) in 1912 reported that the bleeding time was prolonged in this affection.

He also noted that the purpurio mani-

festations closely followed the platelet count and produced the
disease in rabbits by reducing the platelet count with diphtheria
toxin and benzol.
In short until reeent years. at leastJ the history of

(6)

thram.bocytopenio purpura has paralleled that of the platelet
and were more known of the physiology of the platelet today.
more might be known of purpura hemorrhagica.

Pure skepticism

however. finally backed by experimental and clinical data has
reduced the importance of the thram.bopenia in this affection.

THE BLOOD PLATELET AND ITS CLINICAL SIGNIFICANCE AS
ULATED TO TBROMBOCYTOPENIA PURPURA

The platelet in health may be defined as a round or oval
disk-like body with an average diameter varying between two and
three microns,, and with a hyaline cytoplasm containing numerous
granules.

It was discovered as early as the middle of the last

century by Donne and .Arnold (23) and called "blood platelets" by
Bizzozero (12).

The existence of a third morphological blood

element has been repeatedly affirmed and denied.

Ka.thews (77)

believed the blood platelet to be merely a precipitate .formed in
altered blood plasma.

Roskam (98) on the other hand showed that

the particles of precipitated plasma bore no resemblance to
blood platelets in size. shape or staining reactioJlS.
(13)

Bizzosero

was the first respol18ible for asserting their imependence as

blood elements.

Hay• (41) and Kemp (56) thought the platelet

to be erythroblastic in origin and this idea ultimately prevailed until 1906 when . .ight (117) made a comprehensive study ot
the platelets, their morphology and relation to the myelogenous

(7)

tissue.

He found the platelets to correspond closely in structure

to the megokaryocyte of the marrow. having a red and purple granular central area surrounded by a eyaline blue border.

These

megokaryocytes he found to have paeudopods. segmented at intervals with
granulated center, h&ving the appearance of a stock of platelets
connected to the giant cell.

It was his conception that these

pseudopods, extending into the marr.ow sinusoids became broken off,
the resultant irregular fragments becoming platelets•
con.i'irmed by Bunting (17) and others.
a closed question.

This work was

Aschoff (3) considers it

Also, in support of this conception Wright and

others point out the parallelism between the number of circulating
blood piatelets and the number of megoka.ryocytes in the bone marrow.
Both are increased in regenerative states.following on hemorrhage
and toxemia, in inflammatory states, in :m;yelogenous leukemia (118)
in Hodgekins disease, in experimental conditions £ollowing the
innoculation of diphtheria toxin (24) and antiplatelet serum (67).
More direct proof is ottered by the observations of Sabin (101)
who watched the clumping of granules and fragmentations of the cy-

toplasm into typical platelets, in megokaryocytes of the bone
marrow in vital preparation.

In same instances, small plate-like

portions of the cytoplasm. became attached to the peripher.y of
. the cell by a narrow stalk until

ultimately the cytoplasm of

these cells had become almost completely fragmented into small
.irregular oval and granular masses lying free in the surrounding
medium.

Bedson and Johnston (6) on the other hand interpreted

(8)

this appearance as degenerative and not productive. Arter injecting antiplatelet serum. they saw no megokaryocytes in the stage

ot active platelet budding but did note an increased number

~t

megokaryocytes in the bone marrow which is in support of· wright's
theor;y. Le Sourd and Pagniez (67} found that like the platelet,
the megokaryocyte produced retraction of' the clot. concluding a
genetic relationship between the two.
It may be added that although these considerations eliminate
the er;ythrooyte and

leuc~cytes

as precursors of' the platelets.

still evidence is not overwhelming in favor of the megokaryocyte.
This is because most of the evidence is based on morphological
and tinctorial observations.

However it seems reasonable to suppose

that the platelet is an independent element and has orgin in the
bone marrow if not other potential hemopoetic tissues in time of'
stress. (23)
Like the red blood cells. however, the platelets are supposedly destroyed by the phagocytic action of cells of the reticulo-

endothelial system, a system discovered mainly by the efforts of
ASchoff (3).

In the strict sense. this system. is composed of

the reticulum cells of the splenic pulp, the cortical nodules and
pulp cords of the lymph nodes and remainder of lymphoid tissue,
the reticulum cells of the sinuses of the lymph nodes, the blood
sinuses of the spleen, the capillaries of the liver lobules
(Kupffer's cells) and the capillaries of the bone marrow, adrenal
cortex and hypopeysis.

t"'\

This destruction capacity has been dif'-

(9)

ficult to demonstrate on h\D'llan beings.

The spleen constantly contains

·1arge numbers of platelets in health and may be seen in the splenic
sinuses when a portion of that organ is teased out in a suitable
medium
and properly stained (6,7).
.
.
.

Spleneotomy, experimental or

therapeutic is followed by an increase in the circulating platelets (6,7) and blood.of the cubital vein and splenic artery contain
more platelets than blood from the splsnic vein (16).
In

contradistinction it must be rem.EID.bared that an increase

in platelet count follows other operative·procedures, experimental
or therapeutic (6,8, 7).

Furthermore an increase in the n\D'llbers

of circulating platelets does not always follow splenectomy (15)
although spence (102) believes this is due to a. diseased extrasplenio reticulo-endothelial system.

One must also conaider that

the spleen acts as a reservoir for red blood corpuscles and
therefore the platelets may be retained for storage purposes and
not for destruction.

Proof is offered here in that injection of

ephedrine or adrenalin which produces splenio contraction is followed by a rise in the number of circulating platelets.
Some investigators claim to have observed phagocytosis of
degenerated platelets within the endothelial cells of the spleen.
It is interesting to note that when the function of the retiouloendothelia.l system is "blocked" such as by the injections of
trypan blue, there is an increased number of platelets in the
circulation (7, 59, 112).

If splenectamy is performed atter

blocking, the platelet count does not rise :t'urther.

However,

(19)
the blocking is only temperarily effective and it may be that
other tissues take over the tu.notion of the retioulo-endothelial
syst••
It is quite probable that a great number of platelets are
produced and destroyed each day.

Duke (24, 26) found that the

total number of circulating.platelets could be regenerated
within three to five days.

Ma.okay (76) in counting the plate-

lets of thirty health subjects found the

~ount

to range from

250,.000 to 450,.000 with individual variations amounting to as
200,.000 in the same day.

Thus it would appear that the plate-

lets delicate structure a.nd its ease of degeneration and regeneration,
its life is probably short.

PATHOGENF.SIS

The most thought-provoking phenome:na. found in this affection
·is the thrombopenia, not only because it aids in the differentiations from the forms of purpura, but because it supposedly was
responsible in 'Whole or in part for the symptomatology and tended to reveal,. at least in pert, the pathogenesis •
.Assuming, as

119

must for the present, that the genesis of

the thrombocyte is from the megokaryocyte of the bone marrow,
and its doom in the phagocytosis of the reticulum cells, then it
might be supposed the ultimate cause for such depletion either
lies in an illhibition of formation or increased destruction at

{ll)

•

these two terminals •
Frank .(33). professor of Internal Medicine in the University

of Breslau in 1916 proposed the theory that this thi"ombopenia
was due to an inhibitory action on the megokaryocytes of the bone
marrow by a :myelotoxin.

Ka.znelson ( 64) on the other hand believ-

ed the spleen to be responsible for an excessi-ve destruction of

the platelets.

In dogmatic fashion he did not believe the con-

dition could exist without the thraabopenia.

He.boldly executed

his theory by removing the spleen on one of his patients with
phenomenal results.

Frank explained Kaznelson 1 s success by sug-

gesting the spleen to be the source of some toxic agent acting
upon the bone marrow.

These two theories have added

proponents~and

up to the present day are still antagonistic.
The histopathological reports on autopsied material has certainly added no light to the subject.

196. 36)

(83•

so.

14. 78. 89. 102,

If permitted to draw 8.JJ¥ conclusions, whatsoever, from

these reports it shall have to be in generalizations for the
findings are not constant.

In the final analysis. the bone

marrow reveals an increased number of megokaryooytes and it is
highly probable that this increase represents a canpensatory
h¥P•rplasia rather than a pathological state.

The spleen, on

the other hand. gives a rather constant picture of splenitis,
acute or chronic.
Experimental and clinical data. however, do not conform
with the theory that the platelet deficiency is the sole cause

(12)

of the purpura.

Of primary evidence of this, we have the m.asai ve

amount of data ccnpiled by Cole (18), Le Sourd and Pagniez (69),
Ledingham (62, 63), and.Bedson.

It was Bedson who finally per-

fected the antiplatelet serum so that it produced no hemagglutination, and the new antisera, when injected into experimental. animals was capable or producing purpura.

But the pertinent point of

Bedson's experiments was that aga;r serum injections, which produced a marked thromboeytopenia did not produce purpura unless
anti-red cell aera was added.

He thus concluded that two condi-

tions were necessary for the production or purpura.
1.

Removal of the platelets from the
circulation.

2.

Toxic injury to the capillary endothelium..

Clinically, the return of a thrombopenia af'ter splenectomy
without a return of the purpuric manifestations in evidence that
the thrombopenia is not the sole factor.

Furthermore, though

the purpuric symptoms closely parallel the platelet count in .
most cases, this is not invariable (82, 113, 102).

In a.plastic

anemia, where all eel lular elements of the blood are all decreased, along with the platelets, purpura does not occur.

}(ackay (76)

demonstrated that prolonged bleeding could occur in the presence
or a normal platelet count, and normal bleeding time and the absence of hemorrhage in the presence of a diminished platelet
count.
In the early experimental work it was difficult to reduce

(13)

the platelet count without·also injuring the capillary endothelium.
As has been pointed out, Bedson (9) could considerably reduce the

platelet count with agar serum., but not produce purpura without
damaging the endothelium. or the capillaries. 11bittkower (114)
by means or X-ray-, reduced tb,e platelet count to 19.,000 without

Pulvertoft (93) on the other hand., by- injecting

producing purpura.

atreptoeoccal toxin into rabbits produced a picture ot fulminating
purpura without

~

dim.inition in the platelet count.

Kaznelson (55) and Rosenthol (96) attanpt to explain purpura
in the presence

or

normal platelet counts by suggesting a quali-

tative def'ect in the platelet and point out the variation in morphology or the platelet in this condition.
find no evidence

Mack~

(76) however could

ot this. He believed the platelet reduction to

. be on a toxic basis., perhaps from a metabolic or secretory def'ioienoy., as in pernicious anaemia where the platelet count is greatly increased on liver therapy.

According to this theory the plate-

let reduction is merely a superimposed phenomena -- and is probably due to an interference with normal platelet formation.
T-idy (108, 109) believes the platelet reductions to be
secondary to endothelial damage and hemorrhage;

ye~

he fails to

ex.plain Why- in other conditions such as scurvy, where damage to
the e:api_llary endothelium exists, there is no pronounced thrombocy'bopenia.
E'V8l18 (28) recording the platelet count following splenectOJ!V
in a case of thrombocytopenic purpura. found that it took ninety

(14)

days for the count to return to normal limits.

He believes

two factors are responsiblea-1.

The reticule-endothelial syst-. taking
over the function of the spleen.

2•

Some toxic agent removed by remaval of
the spleen.

However the Nsults of

splenect~

are not so constant

that Evans• theory is applicable to all.

Piney (91) divides

the essential throm.bopenia purpuras into three groups. those
in which there is:

1.

A rapid rise in platelets to a normal
level which is sustained.

2.

A rise after operation followed by
return of purpuric symptoms.

3.

No change in the platelet count though
there was a marked thrombopenia before operation.

These cases often show

clinical improvement in spite of the
platelet count•
It is quite obvious that the role played by the spleen
varies in these three groups.

In the first group. the spleen

is evidently responsible for the low platelet count (either because of marrow inhibition or increased destruction) and the
purpura.

Splenectany would be speci.f'ic in such a .condition.

In the second group. the fall of the platelet count to former

levels might be explained on the basis that the rest of the

{15)

of the reticule-endothelial system has compensated for the loss
of the spleen.

In the third instance, the spleen was probably

not the seat of the trouble.
Lesch.er and Hubble ( 66) believe that the purpuras should
be divided into two groups depending on the causes:1.

Deficient production or megolcaryocytes

~·

Defective separation of the platelet
from.the

~egokaryocyte.

Possibly a third cause might be mentioned, mainly the excessive
destruction by the spleen.
De Sanot.is and Allen (21 )' believe that some agent activates

the reticulo-endothelial system to unusual thrombolytic activity.
The fact that splenectany in acute cases has no effect bears
out this opinion.

They believe recurrences due to the fact

t:m t the reticulo-endothelial system has partially taken over the
function or the spleen following extirpation or that organ.

Ask81' and Toland (4), in regards to the rapid rise

in the

platelet count following splenectomy, suggest· the presence in
the blood stream of a toxin which tends to lower capillary resista.nee yet is so transient in its effects that a continuous supply
is necessary for sustained action.

They believe the spleen to

be the source of the supply since that organ is the only one to
be cut oft from the general circulation in thereapeutic splenectoll\Y•
Yet D18JJiY cases ahwwing clinical improvement with relief of hanorrhage

(16)

after surgical rem.oval of the spleen,, fail to show improvement of
the blood picture,, the platelets remaining low,, the bleeding time
prolonged,, the tourniquet teat positive
tile.

and

the clot non-retrac-

They thus conclude that the whole reticulo-endothelial sys-

tem is involved and that the removal of the spleen is only a
quantitative reduction in the extent of the disease.
'Whatever the etiological agent may be. it still remains
obscure. although recent advances may clarit,y the situation to
quite an extent. Whipple (113) and Tocantis (110) are impressed
with the fact that infection often precedes the onset of purpuric
symptoms and Stewart (105) believes that bacterial toxins stimulate the reticulo-endothelial system to increased destruction
of the platelet. These observation have led to the eradication
of all foci of infections as a supportive measure,, an importaue adjunct to all therapeutic procedures.
The most enlightening work however has just been received
from Troland and Lee (111) who took the spleen of three patients
with Thranboeytopenic purpura directly from the operating roan,,
chopped each into small pieces and placed them in acetone reagent• ·
The supernatant fluid was drained off after a few weeks,, the
residue shaken with distilled water and filtered.

Injection of

the filtra't;e into rabbits in all three cases produced a reduction
in theplatelet count £ran 650,,000,, 640,,000,, and 610,,000 to
58.000,, 10.000 and 100,000 respective4' in twenty four hours.
Repeated injections caused the platelet count to remain low but

(17)

no purpura was evident.
appreciably changed.

The red and white cell counts were not

They suggest the name •thrombocytopen" for

the unknown active principle.

As a control. four organs from

npn-purpuric patients including the spleen of a patient with
hemolytic icterus. were treated likewise 'but produced virtually
no decrease in the platelet count.

The report. however. is

preliminary and will be followed by a more complete report in
the near future.

BLEEDING TI.ME AND CAPILLARY PERMEABILITY

With such pertinent facts as supplied by Bedson (9) we know
that the platelet alone is not responsible for the purpuric manifestations. -- and this will be further substantiated in the
forthcoming discussion.

We must assume that the toxic agent

acts directly upon the endothelial lining of the blood vessels.

As we

have stated. Pulvertoi'ti (93) has shown that a fulminating

purpura can be

produ~ed

inthis way without &Jl1 thrombocytopenie..

Duke (24) pointed out the relation of' spontaneous capillary
hemorrhage, bleeding t.iae and the number of' ciruclating platelets.

Accordingly. he :touDd that the bleeding time and the pur-

pura were inversely related to the number _of' platelets•

He

discovered that purpura rarely occurred when the platelet count exceeded 40.000.

lt was a natural assumption to regard the thrombo-

cytopenia as the cause of the purpura.

Evidence of this relation-

(18)

ship exists in other diseases such as acute leukemia. pernicious
anaemia. diptheria. hemorrhagic small pox. and in such experimental work with diptheria toxin (5. 53) benzol (7) and antiplatelet serum. (10).

Duke believed.the platelets adhered to the

edges of the injured endothelium. thus closing the wound and
preventing hemorrhage.
Frank (33) in 1913 stated that a normai in&act capillary
will not permit diapedesis or hemorrhage with resultant purpura.
He believed that there must be scae damage• or at least an increased povosity of the capillaries. The capillary resistance
test of Ress (43) impresses us with the same idea.

ll~rmally

af'ter a tourniquet has been firmly applied to the upper extremity so that the venous r_eturn but not the arterial supply is
obstructed, petechiae do not appear distal to the tourniquet.
In thrombocytopenia. however, small capillary hemorrhages ap-

pear below the point of constriction.

Such bleeding is produc-

ed by an increase in the venous pressure.
The pathology is not definitely known. Rouget (99) in
1873 first called attention to the existence of peculiar contractile cells on the walls of the capillaries. Aschoff (3)
de~ed

that these cells were contractile but stated they were

part of the reticul-endothelial system. Whipple (113) states it
is conceivable to suppose. since the cells of Rouget belong to a
system stimulated by the same agent ·as other parts of the retiouloendothelial system, then

the~e

cells might be responsible for

(19}

the disturbed permeability of the capillary walls. allowing
the passage of blood into the tissues. Aschoff believes that
there is some softening of the intra-cellular cement substance•
Bedson (9) describes the typical vascular lesion present
in all cases of Thrombocytopenic purpura.

Histological exami-

nation revealed changes in the vascubr endothelium. similar to
those described by Findley for experimental scurvy; namely a.
swollen edematous appearance of those cells.

He placed the

mesenteric vessels of an anaesthetized guinea pig under observation
and experimentally prod,uced purpura by i?Ulooulation of antiplatelet serum. ·Within a short time hemorrhages were observed
under the microscope along the course of the vessels. yet there
was no appreciable slowing of the current nor plugging of the
vess.els.

The majc:irity of the hemorrhages appeared to be an

exaggerated form of diapedesis.

Bedson suggests that the hemorr-

hage pr"obably would no-t occur with an adequate number of platelets for the platelets and the white blood cells flowing at the
periphery would block the escape of the centrall.7 moving red
cells. were the blood stream appreciabq slowed by the SirOllen
endothelium it might be argued that the platelets. adhering to
to the lining cells would eventually plug the vessels and lead
-to its rupture.

However there is not much evidence to support

this view.
Kemperer (57) did find this to be the case in four oases of
clinicalq acute thrcmbocytopenic purpura.

The vascular lesions

{2D) .

appearing in the capillaries and smaller arterioles.

The af-

fected vessels were dilated and the lumen completely occluded
with granular thrombi.

The lining endothelium at these sites

showed swelling anq proliferation and in JD8.I\Y' places the thrombus
showe actual invasion with proliferating endothelial cells resembling houng fibroblasts.

Various stages of organization could be

seen in the same organ. some thrombi were still. mural.

They be-

lieved the vascular thrcmbosus occurred in repeated attacks and
the endothelial proliferation to be a response to the throm.bolytio
occlusion of the lumen.

In ten other cases of acute and seven of

chronic thrombocytopenic purpura no such pathology could be
observed. These investigators believe the depletion of platelets to be due to the w.st number composing the thrombi, a theory
that is similar to that of Tidy {108).

It was int.-esting to note

that a brother of one of the four cases cited above also had
purpura, clinically identical but no such pathology was observed.
The vaso-constriction action, concomitant with hemorrhage.
has long been known.

Al early as 1869. Ludwig {75) and Schmidt,

perfusing the muscle of a dog with blood serum, encountered an·
unexpected resistance to the flow of defibrinated blood. Early
investigation believed the effective element to be epinephrin.
O'Connor {84) however found that the action of the serum was not
the same as for epinepbrin and that the stimulating agent entered
the blood during the process of clotting.
con£irm.ed this.

Janeway and Park {49)

O'Connor {84) also mentioned that extracts of

(21)

of platelets produced a powerful -vaso constrictor action on the
~rterial

ring.

Stewart and Tucker (103, 104) appended a _foot note

to this effect, for it fitted in with their findings, offering
a relation between the vaso constricting action of the serum an:l
the formed elements of the blood.

These investigators .found

that the pressor action was due· to a substance formed when the
fonned elements of the blood were shed.

This change occurred

concomitantly with some of the changes preliminary to clotting
and nob as the .fibrinogen was converted into fibrin.

Their results

also implied that the vaso constrictor effect of the serum was
an important adjunct in the role of sealing of important vessels.
Janeway, Richardson and Park (49) verified the findings of o•eonnor that the extracts of platelets produced a powerful vaso constriction action

but~could

produce no such effect with the extract of

erythrocytes or leucooytes.

Since the circulating plasma of nor-

mal animals produce no vaso constriction and since plasma can
be taken from the vessels without vasoconstriotion occurring,
they were -led to conclude "bha.t the substance responsible was
liberated after the plasma escapes from.the blood vessel.
Hirose (44) found that the effect of defibrinated blood on
the carotid artery was roughly proportional to the platelet
count.

In cases 'Where the pla"belet count was extremely low, the

defibrinated blood had little or no vaso constricting property.
Tha:t there is a relation between capillary tone and the blood platelets seems to be true.

Furthermore, loss of capillary tone leads

{22)

to increased capillary leakage. 1fe may thus conclude that aey- great
quantitative or qualitative change in the platelet preventing the
supply of vaso constrictor substance would encourage the loss of
vasomotor tone and the production of capillary hemorrhage.
McLean (78) on the other hand• states that the severity of
capillary bleeding is not in proportion to the number of platelets. severe bleeding occurring in the presence of platelet counts
varying from 10.000 to 140.000.

He believes the lowered capillary

resistance to be due to the activity of the same agent responsible
for the change in quality or number of platelets and also for the
irritation of Rouget'a cells and the softening of the intracellular cement substance of the capillary walls.

-.ckq {76) fully

agrees with McLean due to variations in his own oases where no
hemorrhage occurred when the platelet count on two patients were
14.000 and 40.000 respectively.

The constancy with which the low

platelet count parallels the bleeding time is due both to vascular permeability and platelet reduction.

Lescbke (65) states that

the contraction of the capillaries is absent or diminished in
purpµra and Mackay thinks that the hemorrhage is due tothe inability of the walls to contract.

Bermuth (11). on the other hand•

observed norm.al capillary response in this disease.

It is quite

obvious that more experimental work will have to be done on this
point before its relative importance am be properly evaluated.

{23)

CL<J.r RETRACTION

Normally when whole blood is taken from a.vein before it
has mixed with 81.lY tissue juices, and allowed to stand in a
container, it becomes gel-like in consistency after two to
six minutes so that the container can be inverted without
spilling the blood.

Soon the agglutinum. begins to retract

fran the edge of the vessel, exuding serum as the process occurs.

Under standard conditions, this process is complete in

eighteen hours.
In essential thrombocytopenic purpura hemorrhagica, the
clotting time is normal, but retraction is either delayed or does
not occur.

The normal clotting time and failure of retraction was

first noted by Hayen (42) in 1896.

Glanzmann (38, 39), LeSourd and

P&gniea {70) believed a platelet ferment to be the cause because
platelets were the only blood elements to undergo decompostion
during the process of coagulation.

Frank (34) thought retraction

to be due to shrinkage of the platelets.

The process of coagu-

lation is an intricate phenomenan and not clearly understood in
spite of vast amounts of research.
of coagulation is accepted.

At present Howell's theory (45)

Briefly, the theory states that the

circulating plasm.a. contains three essential £actors of coagulation,
fibrinogen, prothrombin, and calcium salts.

Coagulation is

prevented because prothrombin is kept inactive, even in the pres-

I""'·.

ence of the calcium ion by an inhibitory substance, heparin. 'When

(24)

blood is shed without coming into contact with the tissue,, the
platelets degenerate and liberate a tbromboplastic substance related to cephalin which neutralizes heparin and allows prothrombin to be converted into the active principle,, thrombin.
The fibrinogen then reacts with the thrombin to form a firm
deposit of fibrin crystals which in vivo prevents further escape of blood.
Reuben a.nd Clemens (95) state that blood deprived of its
platelets content will not clot unless tissue extracts or
platelets are added.

Brill and Rosenthal (14) believe that

the failure of clot retraction is due to a qualitative change
in the platelet.
The failure of syneresis to occur has also been noted
in pernicious anemia, a.plastic anemia, and Banti's disease
(97) where the platelets fall below 100,,000.

If a splenecto:my

is performed,, the clot retracts coincident; with the platelets
increase (19,, 107,, 84).
It has been experimentally shown that retraction occurs in
proportion to the number of platelets in blood plasma. (70) or
in hydrocoele fluid (71).

Furthermore in animals that have been

deplatetized there is a failure of clot retraction until the
platelet count; returns to nona.al (62,, 64 ),, then two agents
which modify or destroy platelets likewise affect. syneresis (70,,
72).

Wide variations in relation to retraction and the platelet

(25)

count have been clinically reported (113. 19) but this variation
is probably due to errors in laborator,y technique.

This is large-

ly due to an adhesive property between the clot and its container
preventing retraction when, under standard conditions, retraction
would occur (46, 90).

:V.ckay (76) believes this relation of

platelet and retraction doubtful due to variance in his own cases.
Archard and

~

(2) found that blood which was deplate-

tized with gelatin, gum and lecithin injections, retracted.
This has also been noted af'ter deplatelizationwith peptone and
thymus nucleic acid (90).

Le Sourd and Pagniez {7S) found that a cha:iige in the l.wdro-

gen ion concentration, by addition of calcium, caused retraction
which was known to be absent at the time of experimentation,
demonstrating that the plasma is an important factor.
Howell, (46) found tmt when the blood was increasingly
alkalinized, a point; could be reached when the fibrinogen became
transparent yet which would not retract.

Furthermore free oxy-

lated plasm.a or pure fibrinogen showed marked retraction properties when thranbin was added and Howell believes the platelet
may be a source of this material.
Mackay (76) believes that the retraction property of blood
is inherent in the plasma, and that the platelet only augments
this property".

Thus we must assume that where no retraction occurs,

there is a· fundamental alteration in the plasma.

Tocantis (110)

is quite in sympatI:w with this theory and believes that syneresis

(26)

is not dependent upon the platelet al'though this element promotes
retraction and prevents adhesion between clot and container.

DIAGNOSIS

To mention that th.a diagnosis ahould be assured before the
more radical types of treatment are resorted to, perhaps seems inconsequential. yet the mistake has been made more than onoe of
subjecting a patient to splenectan;,y when the affection turned
out to be a JDY'&logenous leukemia in an a.leukemic phase.

The

differential diagnosis should never be lightly considered.

Chief-

ly among 'the affections to be eliminated are:1. Hemophilia
2. Aplastio anaemia
3.

Leukemia

The diagnosis .from hemophilia·can be made on the basis of
non-traumatic origin of bleeding,, lack of familial history,
normal clotting time, prolonged bleeding time, absence of clot
retraction and thrombocyt9pen1a.

In

acute aplastic anaemia all

elements of the blood are depleted. There are no nucleated reds
and there is a decisive leukopenia whereas in the thrombocytopenic

purpura,, aleucocytosis is the rule.

The chief diagnostic poin1;,

in leukemia is the presence of young white cells ixi the blood.
Not only the diagnosis of typical cases but also the recognition of atypical case will give the practiilioner much dif'fi-

(&?)

culty.

Recognition of new groups within the general heading

of Essential thrombocytopenic purpura. is to be expected at a
tuture date.

Some cases appear to be hereditary or familial.

Prolongation of the bleeding time without paucity of the platelet has been described.

Furthe~

study will be necessary

be~ore

a correct subdivision can be accurately made.

The types of t reatmene for thrombocytopenic purpura are
~

and

varied~

To a great extent therapy depends upon the

phase and severity of the disease,, the age of the patient,, degree
of exse.nguination,, etc.

For practical purposes we may divide

the treatment into conservative and radical,, i.e.,,

non~operative

and operative.
transfusions seem to be the most popular type of conservative therapy.

Larrabee {6l),J0 nes

(~,,

Moffat (81) and Tacantis

(110) report cases where repeated trans.f'usions have produced
remissions without subsequent

recurrences~

Such treatment.

however, is .tr from being uniformly successful, but when
effective, controls hemorrhage,, increases the red cells and
platelets and in general is a valuable supportive measure even
when not curative.
Other conservative mthods have been tried with varying

I'"\

degrees of success.

Jones (52) recommends the administration

(28)

of calcium. or parathonnone.

Dixon (22) reports four cases

treated successfully with autogenous blood.

Liver therapy has

been tried suceesstully with Jacob (47) and Jones (52).
coast. Pendergrass, &Ild Fitz Hugh (85) believe that

Pan-

roentgen

rays should be given for temporary relief. Rudisill {100)
treated 6 cases with x-ray--producing rapid relief in each case
and no remissions.

Mettier~

stone, and Perviance (79) treated

five cases wi.th X-ray and found the platelets to rise as much
as 250,000 or 500,,000 in nine days.
six cases wi.th ultra violet.
&Ild two,, clinically acute.

McLean, et. al. {78) treated

Four or the cases were chronic

or

these six. one died due to ina-

bility to find a donor for transfusion; but the rest suffered
no recurrences during the entire period of observation (eight
months to five and one half years), and the platelet count remained within normal limits in three cases for over two years.
Jones (51) and Giffin {37) also recommends its use and believes
that a high vitamin B and D diet should be administered to these
patients.

Thramboplastin has also been tried therapeutically (51)

&Ild non-specific .protein shock: with horse serum., milk and human

blood ha:ire been tried with a lesser degree of success (30).
The use of anti-venom as a therapeutic agent has also came
into limited use by certain clinicians.

Taylor {107) reported

rapid recovery in four of five patients treated with antivenan,,
and recommends its use in f'ulminating cases where splenectcmw

I"":

carries such a high mortality rate.

feck (87) expresses the

(29)

view that the action of a.ntivenom is on the capillaries and the
mechanism of coagulation.

Ir this is so. the et.feet should be

(and is) temporary. and thus like other forms of conservative

therapy is not curative but produces remission of symptonu;.
Peck and Rosenthal (88) treated 13 cases with antivenom and found
nine cases showed improvement. with symptomatic and hemotological
relief in four.

F~r

cases showed only slight temporary relief.

Rosenthal {88) however. believes that the remissions may be
spontaneous.

He concludes that th±s type of

ther~py

is of aid

in shortening the period of conve.lescense in patients in the early
stages of a remission.

Gr~enwald

(4') had similar success and

recommended it along with transfusions to be used before splenectomy and in cases where operative procedure did not actively
curtail the hemorrhagic diathesis.
SplenectOJ'l\Y has long been the treatment of choice in this
affection since Kaznelson

firs~

achieved his brilliant results.

Eliason and Ferguson {27) in 1932. reporting two hundred thirteen
cases in literature. including those canpiled by Whipple (113)
and Spence (102) and five of their own. give the following results.
The total mortality rate prior to 1932 was 13.1%, a reduction
of 7% for the t'.igures given prior to 1928.

There were 81.2% of

the operated cases cured or definitely improved •
.Among the acute cases, there was a total mortality rate of
34.3%.

However, the .figures .for the period between 1928 and

1932 were only 13.6% in comparison to that o.f 83.3% reported by

(30)

Spence in 1938.
In the chronic cases. there was a mortality rate of' 7% for the

whole series against a 11.8% mortality rate reported by Spence.
In these cases there was cure or improvement in 88.l" of the cases •

.Among the acute cases all but one died on the operating
table following operation.

In all probability these patients were

well exsanguinated a.t the time 0£ operation.

The phenomenal de-

cline in the mortality in these cases is expained by Eliason and
Ferguson as due to earlier surgery and more adequate preparation
'tiefoi'e surgery.
The above statistical data proves conclusively that the
chronic oases are better surgical risks than the acute ones.
But just what to call a chronic or an acute case of' purpura
hemorrhagica is often difficult to ascertain.

'Whipple (113) states

that a ct,ae is chronic when the patient has recurrent attacks of
bleeding from the gums and nose. peteehiae and ecchymoses.

men~

orrhagia in women, but no bleeding into the alimentary c8.D&l or
parenclJ¥ma, of the internal organs.

Because splenectomy produces

a cure in these cases•he believes they represent a true disturbance of the reticulo-end.othelial system -- a system in which the
spleen pl81's a major role •
. Spence (102). Fib. Hugh (31). and Jones (50) as well as
others a.re in agreement with this theory. Williamson limits
operation to those cases in which the patients development and
health are interferred with or where the bleeding is so profuse
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as to endanger the patients life.
Giffin (35) offers the following results of

splenect~

at Mayo Clinic and draws his own conclusions. He believes that
chronic ca.sea of mild severity should be treated symptomatically,
with elimination offoci of infection, diet, iron and transfusion
if necessary.

In twenty five cases of moderate and severe chronic

cases operated at Mayo•s, the mortality rate was zero.

But re-

currences occurred in seven cases which, for the most part, were
mild.

In nine cases of acute exaceriations of chronic purpura,

there was only one death, and that due to an intracranial hemorrhage before operation. All had mild recurrences.but are well.
Giffin believes the patient should be given every opportunity
for spontaneous remission before splenectom;y is resorted to.

He believes it doubtful if patients, showing acute exacerbations
can be cured by splenecto:my if they do not respond to transfusion.
On the other hand if transfusions do not produce a response,
operation should not be delayed longer than is mcessary.

In the

acute cases he believes that splenectci>m¥.is only indicated when,
in spite of transfusions,, etc., that patient is on a down-hill
course.

This is probably the general at1?itude at present among

medical men.

However, the trend is definitely toward splenecto:my

regardless of the chronioity.

(32)
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. CASE REPORT

A white schoolgirl. age nine. entered the University
Hospital on February 28, 1938.

Two

weeks prior to Christmas,

1937. while convalescing from a sore throat and cervical adenitis, small, slightly elevated black spots spontaneously appeared on the hips. arms, and legs.

These areas gave the appearance

of bruise marks although there was no history of trauma. A few:
days before Christmas the patient had three spontaneous nose
bleeds of moderate severity and another on Christmas day,. which
lasted several hours and lett her pale and :weak.

Her physician.

seeing her for the first time, ordered her to bed and gave her a
high vitamin C diet., believing the condition to be scurvy.

She

improved considerably until January 3. 1938, when the bluish
spots reappeared spontaneously over the entire body and the
temperature rose to 102 degrees.
severe nose bleed and fainted.

On January 17, she bad another

She was immediately transfused.

She suffered three recurrences the following m.onth. including
hemorrhage from the nose and gums, and a transfusion was the
method of treatment in each case.

Ordinary hemostatics seemed

useless in attempts to curtail the hemorrhage. .On Februar,y 21.,
she received the fourth

t~ansfusion.

Since that date she has

shown considerable improvement, the skin bas cleared, and she
has had no more active bleeding.

She was sent into the University

hospital by her physician with a diagnosis of Essential Thrombo-
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oytopenic purpura.
No hereditary nor familial relationship could be found in
the history.

She had had pneumonia., small pox, measles, mumps,

chicken pox, pertussis, and frequent sore throats accompanied
by cervical adenitis.
On entrance, the patient was well nourished but very pale.

There were blood crusts in the external nares and the nasal
mucous membrane was dry and crusted.
the gums had a purplish tinge.

The lips were pale and

There were two carious teeth.

The tonsils were large and moderately inflammed and thtre was
a moderate bilateral submaxillary adenitis.
clear.

The lungs were

A faint systolic murmur was audible over the apex of

the heart and there was a questionable enlargement of the heart
to the left.

The spleen was not palpable but percussion showed

it to be enlarged and

subsequ~nt

X-rays of the abdomen gave the

impression that it was twice normal size.
There was no active bleeding. A bluish discoloration over the
right iliac crest measured 10Jt4 om.

There were also ecchymotic

spots in the right anti-cubital fossa and on the right thigh.
The tourniquet test was strongly positive, the bleeding time
prolonged--(7iminutes) 1 the platelet count only 96,0001 and
no clot retraction in the face of a norm.al clotting time of ten
minutes.
Dr. Hamilton thought it advisable to pursue a conservative
course to allow for observation and thorough hematological studies.
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The patient was placed on a general diet and givenan additional
six ounces of orange juice a d81'•
As can be seen from the aocomp8.J7¥ing table. the platelet
count slowly tell to the low level or 40.000, yet no bleeding
occurred.

The tourniquet test was strongly positive, however.

and the least trauma produced ecchymosis.

On

March 11. she

was transfused with 300 cc. or citrated blood, but though the
red cells showed a substantial increase, th.8 platelet count remained

~ltered

and the bleeding time prolonged.

On the

16th, reticulogenwaa pegan and following a latent period or
three days the platelet count jumped to 102,000.
all probability should be interpreted as a

This rise in

spontane~us

remis-

sion tor a week later the count dropped.to a new low level or
32,000.

On the 26th, she had a nasal hemorrhage and vomited

twice, the vcmitus containing bright red blood.
On March 3oth, following surgical consultation it waa

decided to

~o

one more conservative attempt,-thia time with

moccasin venom. Af't;er the first administration the bleeding
time increased 'bo two hours. but the platelet count remained
around the same precarious level.

The following dq she had

a slight nasal hemorrhage and there was a persistent oozing
until April 3, when whe was again transfused andthe snake venom
discontinued.

There has been no bleeding since transfusion.

She will probably be transfused once again a.Di then

r.

will be performed.

splenect~

(35)

The case is quite typical of an acute thrombocytopenic purpura which has now passed into the chronic phase.

It is this

type of case most amendable to treatment by aplenectonw. and
since her physical condition is excellent at present. operation
should result in marked relief or cure.
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.ADDITION.AL LABORATORY DATA

Sedimentation Rate:

24 mm. in 1 hour and 23 minutes.

Fragility Test: · FrClll .4% Na Cl to .18% Na Cl.
Kahn and Kline (diagnostic)r

Negative

Ditterential Blood Counts Segmented forms----------39
start-------------------- 2
Eosinophiles--~---------- l
Monocytes----~------~----10

~hocytes--------------48

•Subsequent diftereIItiala, in search of young white cells
not recorded. No immature cells fou:nd.
Blood Sllleara

Reveals variation in size and shape ot the red cells w.ith a preponderanee of microcytesJ moderate achromia and slight polyohromasia.
No abnormal white cells.

..........
CA

CX>
...._,

)

)

J
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